FC
RMD icon

FCA Corp’s ResMed RMD Stock Holding History

FCA Corp’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,000
Closed -$219K – 178
2023
Q2 		$219K Buy
+1,000
New +$223K 0.08% 153

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

FCA Corp's RMD Position: Q3 2023 in Review

FCA Corp sold out of ResMed (RMD) in Q3 2023, closing a stake of 1,000 shares — an estimated $219K sold.

FCA Corp first reported a position in RMD in Q2 2023 and held it in 1 quarter. The position peaked at $219K in Q2 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • FCA Corp reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • FCA Corp sold 1,000 ResMed shares in Q3 2023, an estimated $219K.
  • FCA Corp first reported a position in ResMed in Q2 2023 and held it in 1 quarter.
  • FCA Corp's ResMed position peaked at $219K in Q2 2023.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on FCA Corp's 13F filing for Q3 2023, filed 13 Nov 2023.